Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066)
Clinical trial NCT02204475 · WITHDRAWN
Trial details
- NCT number
- NCT02204475
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.